Page last updated: 2024-11-03

praziquantel and Appetite Disorders

praziquantel has been researched along with Appetite Disorders in 1 studies

azinox: Russian drug

Research Excerpts

ExcerptRelevanceReference
" INTERPRETATION/SIGNIFICANCE: PZQ treatment is as safe and efficacious in children aged 1-5 years as it is in older children aged 6-10 years in whom PZQ is the drug of choice for control of schistosome infections."2.76Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. ( Appleby, L; Bourke, C; Mduluza, T; Midzi, N; Mitchell, K; Mutapi, F; Nausch, N; Rujeni, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mutapi, F1
Rujeni, N1
Bourke, C1
Mitchell, K1
Appleby, L1
Nausch, N1
Midzi, N1
Mduluza, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment[NCT02495909]700 participants (Actual)Observational2016-02-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for praziquantel and Appetite Disorders

ArticleYear
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
    PLoS neglected tropical diseases, 2011, Volume: 5, Issue:5

    Topics: Administration, Oral; Animals; Anthelmintics; Appetite; Child; Child, Preschool; Feeding and Eating

2011